For example, abatacept is effective in patients with CTLA4 deficiency, as seen in a patient in our study, and HCT is known as a therapeutic option for treatment of XIAP, CGD, and IL-10 deficiency and associated IBD-like colitis. This evidence concerns the gene XIAP and inflammatory bowel disease.